CN1221273C - Medication composition for diabetes - Google Patents
Medication composition for diabetes Download PDFInfo
- Publication number
- CN1221273C CN1221273C CN 02135518 CN02135518A CN1221273C CN 1221273 C CN1221273 C CN 1221273C CN 02135518 CN02135518 CN 02135518 CN 02135518 A CN02135518 A CN 02135518A CN 1221273 C CN1221273 C CN 1221273C
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- rhizoma
- diabetes
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a medication composition for treating diabetes, which is prepared from astragalus root, water plantain, fragrant solomonseal rhizome, milkvetch seed, Chinese yam, wolfberry bark, matrimony vine, etc. according to a certain proportion. The medication composition for treating diabetes has the advantages of good therapeutic effects, high curative rate, no relapse after healed, obvious effect and no toxic or side effect.
Description
Technical field
The invention provides a kind of medicine for the treatment of diabetes.
Background technology
Diabetes are a kind of commonly encountered diseases, frequently-occurring disease, and the trend that increases is year by year arranged.The medicine that adopts is generally sulphanylureas, biguanides and insulin etc. at present, and these drug side effectes are big, and therapeutic effect is also relatively poor.The Chinese medicine medicine that some treatment diabetes are also arranged now loose and diabetes pill etc. as LIUWEI DIHUANG TANG, Yuquan, but therapeutic effect is also not ideal.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of pharmaceutical composition for the treatment of diabetes, to improve its therapeutic effect.
The present invention is achieved in that a kind of pharmaceutical composition for the treatment of diabetes, and the proportioning of described pharmaceutical composition is:
The Radix Astragali 25~40 weight portions
Rhizoma Alismatis 5~15 weight portions
Rhizoma Polygonati Odorati 5~15 weight portions
Semen Astragali Complanati 5~15 weight portions
Rhizoma Dioscoreae 25~40 weight portions
Cortex Lycii 10~20 weight portions
Fructus Lycii 10~20 weight portions
Rhizoma Atractylodis 10~20 weight portions
Radix Scrophulariae 25~40 weight portions
Radix Salviae Miltiorrhizae 25~40 weight portions
Radix Puerariae 5~15 weight portions
Radix Trichosanthis 25~40 weight portions
Herba Eupatorii 5~15 weight portions
Radix Codonopsis 10~20 weight portions
Rhizoma Coptidis 5~15 weight portions.
The pharmaceutical composition of this treatment diabetes, therapeutic effect is good, the cure rate height, prognosis is not recurred, and instant effect has no side effect.
The specific embodiment
Further specify the present invention below.
A kind of optimum ratio for the treatment of the pharmaceutical composition of diabetes of the present invention is:
The Radix Astragali 25~35 weight portions
Rhizoma Alismatis 6~10 weight portions
Rhizoma Polygonati Odorati 6~10 weight portions
Semen Astragali Complanati 6~10 weight portions
Rhizoma Dioscoreae 25~35 weight portions
Cortex Lycii 10~15 weight portions
Fructus Lycii 10~15 weight portions
Rhizoma Atractylodis 10~15 weight portions
Radix Scrophulariae 25~35 weight portions
Radix Salviae Miltiorrhizae 25~35 weight portions
Radix Puerariae 5~10 weight portions
Radix Trichosanthis 25~35 weight portions
Herba Eupatorii 6~10 weight portions
Radix Codonopsis 1~15 weight portion
Rhizoma Coptidis 5~15 weight portions.
The instructions of taking of the present invention's pharmaceutical composition is, by said ratio, is unit of weight with the gram, forms dose.Its decocting method is identical with the decocting method of existing Chinese medicine decoction.Promptly use cold water soak 30~40 minutes earlier, decocted then 35~45 minutes, take out medicinal liquid, add cold water more therein, decocted 35~45 minutes, take out medicinal liquid.Be divided into two parts after the medicinal liquid that decocts gained for twice mixed, every day is each oral portion sooner or later.
It below is clinical observation material.
Test group: the decoction that oral the present invention's pharmaceutical composition is made.Have 289 examples, wherein male 168 examples, women 121 examples.Age is less than 20 years old 1 example, 20~40 years old 92 example, and 196 examples more than 40 years old adopt above-mentioned fried and take method.30 days is 1 course of treatment.
Matched group: oral " diabetes pill ".Have 103 examples, wherein male 70 examples, women 33 examples.Age is less than 20 years old 1 example, 20~40 years old 31 example, 69 examples more than 40 years old.Instructions of taking is every day 3 times, takes 2.5g at every turn.30 days is 1 course of treatment.
The present invention's pharmaceutical composition is mainly used in the treatment of type ii diabetes.Patient all has in various degree thirsty, polydipsia, polyphagia, polyuria, the symptom such as weak of becoming thin, laboratory examination, and fasting glucose is higher than 6.1mmol/L, on an empty stomach glucose in urine ++~++ ++.The case of test group and matched group is selected, and all meets above-mentioned standard.
Curative effect judging standard: cure, transference cure, laboratory examination, fasting glucose is lower than 6.1mmol/L, on an empty stomach the glucose in urine feminine gender.Effectively, clinical symptom relief, laboratory examination, glucose in urine, fasting glucose etc. all have improvement on an empty stomach.Invalid, clinical symptoms and laboratory examination all do not have obvious improvement.The curative effect situation sees the following form.
Group | Before the treatment (by fasting glucose mmol/L branch) | The example number | After the treatment | |||||
Cure | Effectively | Invalid | ||||||
The example number | % | The example number | % | The example number | % | |||
Test group | 9.8-16.0 | 97 | 95 | 97.9 | 2 | 2.1 | 0 | 0 |
16.0-25.0 | 163 | 153 | 93.9 | 10 | 6.1 | 0 | 0 | |
>25.0 | 29 | 23 | 79.3 | 6 | 20.7 | 0 | 0 | |
Add up to | 289 | 271 | 93.8 | 18 | 6.2 | 0 | 0 | |
Matched group | 9.8~16.0 | 26 | 5 | 19.2 | 19 | 73.1 | 2 | 7.7 |
16.0-25.0 | 61 | 9 | 14.7 | 50 | 82.0 | 2 | 3.3 | |
>25.0 | 16 | 2 | 12.5 | 11 | 68.8 | 3 | 18.7 | |
Add up to | 103 | 16 | 15.5 | 80 | 77.7 | 7 | 6.8 |
As can be seen from the above table, the cure rate of test group is 93.8%, and apparently higher than 15.5% of matched group, the total effective rate of test group is also apparently higher than matched group.The curative effect that shows the present invention's pharmaceutical composition obviously is better than matched group.
To the understanding of diabetes early just there are the record of " quenching one's thirst ", " numbness disappears ", " in disappearing " ancient times in China.Diabetes spp is in the category of " quenching one's thirst ".Successive dynasties medical science thinks, diabetes be, body fluid hot and suffocating because of the lung stomach secretly consumption and deficiency of kidney yin, phlegm-fire high partially be subjected to again scorching due to.Treat appropriate to the occasion benefiting qi and nourishing yin, function of spleen and stomach regulating.In the side, the Radix Astragali, Radix Codonopsis can be mended the gas of strengthening spleen and lung.Rhizoma Dioscoreae, Fructus Lycii, Semen Astragali Complanati liver and kidney tonifying, YIN nourishing and the production of body fluid promoting.Rhizoma Atractylodis, Herba Eupatorii have the removing dampness merit turbid, that be amusing of dispelling.Rhizoma Polygonati Odorati, Radix Trichosanthis, the relieving restlessness of purging heat, promoting the production of body fluid to quench thirst.Rhizoma Alismatis, Rhizoma Coptidis, bitter cold is purged heat, and removing burning wood away under the boiler is in the hope of reinforcement and elimination in combination.
Claims (2)
1, a kind of pharmaceutical composition for the treatment of diabetes is characterized in that, the proportioning of described pharmaceutical composition is:
The Radix Astragali 25~40 weight portions
Rhizoma Alismatis 5~15 weight portions
Rhizoma Polygonati Odorati 5~15 weight portions
Semen Astragali Complanati 5~15 weight portions
Rhizoma Dioscoreae 25~40 weight portions
Cortex Lycii 10~20 weight portions
Fructus Lycii 10~20 weight portions
Rhizoma Atractylodis 10~20 weight portions
Radix Scrophulariae 25~40 weight portions
Radix Salviae Miltiorrhizae 25~40 weight portions
Radix Puerariae 5~15 weight portions
Radix Trichosanthis 25~40 weight portions
Herba Eupatorii 5~15 weight portions
Radix Codonopsis 10~20 weight portions
Rhizoma Coptidis 5~15 weight portions.
2, a kind of pharmaceutical composition for the treatment of diabetes as claimed in claim 1 is characterized in that the proportioning of described pharmaceutical composition is:
The Radix Astragali 25~35 weight portions
Rhizoma Alismatis 6~10 weight portions
Rhizoma Polygonati Odorati 6~10 weight portions
Semen Astragali Complanati 6~10 weight portions
Rhizoma Dioscoreae 25~35 weight portions
Cortex Lycii 10~15 weight portions
Fructus Lycii 10~15 weight portions
Rhizoma Atractylodis 10~15 weight portions
Radix Scrophulariae 25~35 weight portions
Radix Salviae Miltiorrhizae 25~35 weight portions
Radix Puerariae 5~10 weight portions
Radix Trichosanthis 25~35 weight portions
Herba Eupatorii 6~10 weight portions
Radix Codonopsis 10~15 weight portions
Rhizoma Coptidis 5~15 weight portions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02135518 CN1221273C (en) | 2002-09-09 | 2002-09-09 | Medication composition for diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02135518 CN1221273C (en) | 2002-09-09 | 2002-09-09 | Medication composition for diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1481841A CN1481841A (en) | 2004-03-17 |
CN1221273C true CN1221273C (en) | 2005-10-05 |
Family
ID=34146186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02135518 Expired - Fee Related CN1221273C (en) | 2002-09-09 | 2002-09-09 | Medication composition for diabetes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1221273C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127380B (en) * | 2013-01-31 | 2014-05-28 | 关桂英 | Compound preparation capable of curing diabetes caused by diabetes mellitus |
CN104887881A (en) * | 2015-06-24 | 2015-09-09 | 德州学院 | Pure Chinese drug preparation for preventing and curing diabetes |
CN108379538A (en) * | 2018-05-11 | 2018-08-10 | 重庆跃龙生物制药有限公司 | Chinese medicine composition and its preparation method and application for treating diabetes |
-
2002
- 2002-09-09 CN CN 02135518 patent/CN1221273C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1481841A (en) | 2004-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1317027C (en) | Chinese medicine for treating depression | |
CN1899500A (en) | Acne clearing decoction | |
CN1698779A (en) | Toothache relieving oral cavity spray and its preparation method | |
CN101953980B (en) | Allium macrostemon and pepperweed seed mixture for treating chronic obstructive pulmonary disease (COPD) by adopting phlegm removing and turbidity resolving method | |
CN101164593A (en) | Oral liquid for treating kidney disease | |
CN102631595B (en) | Medicament for treating II-type diabetes mellitus and preparation method thereof | |
CN1149097C (en) | Chinese patent medicine for curing diabetes | |
CN1221273C (en) | Medication composition for diabetes | |
CN1364628A (en) | Compound traditional Chinese dmedicine preparation-Manxiening pill for curing chronic diarrhea | |
CN1792372A (en) | Traditional Chinese medicine prepn. for treating diabetes | |
CN1582985A (en) | Medicine for diabetes and its preparation | |
CN1096865C (en) | Chinese patent drug-Yibao for treating diabetes | |
CN1253190C (en) | Medicine for treating diabetes | |
CN100457169C (en) | Medicine for treating chronic colitis and its preparing process | |
CN1127344C (en) | Oral pill for curing diabetes and its complication | |
CN105641419A (en) | Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer | |
CN1158091C (en) | Chinese medicine composition for treating lung cancer | |
CN100345568C (en) | Chinese-medicinal preparation for treating prostatic disease | |
CN1903347A (en) | Medicine composition for treating alimentary canal diseases, prepn. method and application thereof | |
CN1087626C (en) | Stain clearing and face beautifying pill | |
CN1076622C (en) | Chinese medicine for curing nephritis | |
CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
CN106581476A (en) | Traditional Chinese medicine formula for treating diabetes | |
CN1060079C (en) | Chinese herbal medicine composition for curing leukemia | |
CN1883691A (en) | Medicine for treating mammary glands hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051005 Termination date: 20120909 |